ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 45 filers reported holding ADICET BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $867,940 | -36.6% | 633,533 | +12.4% | 0.00% | – |
| Q2 2023 | $1,369,947 | -57.9% | 563,764 | -0.1% | 0.00% | – |
| Q1 2023 | $3,251,272 | -92.0% | 564,457 | -87.6% | 0.00% | -100.0% |
| Q4 2022 | $40,848,398 | +46.7% | 4,569,172 | +133.3% | 0.00% | -50.0% |
| Q3 2022 | $27,847,000 | +300.8% | 1,958,265 | +311.5% | 0.00% | – |
| Q2 2022 | $6,947,000 | -12.3% | 475,856 | +19.9% | 0.00% | – |
| Q1 2022 | $7,923,000 | +38.3% | 396,768 | +21.2% | 0.00% | – |
| Q4 2021 | $5,727,000 | +146.5% | 327,441 | +10.5% | 0.00% | – |
| Q3 2021 | $2,323,000 | -10.1% | 296,247 | +17.9% | 0.00% | – |
| Q2 2021 | $2,585,000 | +1786.9% | 251,197 | +2290.1% | 0.00% | – |
| Q1 2021 | $137,000 | -36.9% | 10,510 | -32.0% | 0.00% | – |
| Q4 2020 | $217,000 | +17.9% | 15,466 | 0.0% | 0.00% | – |
| Q3 2020 | $184,000 | – | 15,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |